In 2010, Ariad introduced outcome from a section I research of ponatinib in patients with resistant and refractory Continual myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). You might not have the ability to grow to be pregnant or get another person pregnant